Moody's Investors Service has revised Doylestown (Pa.) Hospital's outlook to stable from negative.
The outlook revision acknowledges Doylestown's marked rebound in liquidity and improved operating performance following unexpected losses during the first half of fiscal year 2016.
Moody's also assigned a "Baa2" rating to Doylestown's proposed $45 million of series 2016A bonds, $18.8 million of series 2016B bonds and $11.7 million of series 2016C bonds.
The rating assignment reflects Doylestown's strong market position and proactive management team.